| Primary |
| Drug Use For Unknown Indication |
23.7% |
| Pneumonia |
10.1% |
| Pulmonary Tuberculosis |
7.8% |
| Prophylaxis |
7.4% |
| Sepsis |
7.1% |
| Anaesthesia |
6.8% |
| Bronchitis |
4.7% |
| Tuberculosis |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.5% |
| Hypertension |
3.4% |
| Upper Respiratory Tract Infection |
3.4% |
| Sinusitis |
2.8% |
| Pain |
2.7% |
| Septic Shock |
2.6% |
| Infection |
2.1% |
| Bradycardia |
1.7% |
| Infection Prophylaxis |
1.7% |
| Product Used For Unknown Indication |
1.7% |
| Respiratory Tract Infection |
1.7% |
| Atypical Mycobacterial Infection |
1.4% |
|
| Vomiting |
11.0% |
| Rash |
8.4% |
| Bradycardia |
7.1% |
| Pyrexia |
7.1% |
| Clostridium Difficile Colitis |
6.5% |
| Thrombocytopenia |
6.5% |
| Urticaria |
6.5% |
| Torsade De Pointes |
5.2% |
| International Normalised Ratio Increased |
4.5% |
| Renal Failure Acute |
4.5% |
| Ventricular Tachycardia |
4.5% |
| Pneumonia Aspiration |
3.9% |
| Tendonitis |
3.9% |
| Diarrhoea |
3.2% |
| Rhabdomyolysis |
3.2% |
| Wheezing |
3.2% |
| Clostridial Infection |
2.6% |
| Hypotension |
2.6% |
| Tachycardia |
2.6% |
| Uveitis |
2.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
19.8% |
| Pneumonia |
7.9% |
| Sepsis |
5.6% |
| Rheumatoid Arthritis |
4.9% |
| Septic Shock |
4.1% |
| Respiratory Tract Infection |
3.8% |
| Bronchitis |
3.6% |
| Mycobacterial Infection |
3.6% |
| Pulmonary Tuberculosis |
3.4% |
| Hiv Infection |
3.0% |
| Pneumonia Legionella |
2.6% |
| Hypertension |
2.4% |
| Anaesthesia |
2.3% |
| Pain |
2.1% |
| Prophylaxis |
2.1% |
| Atrial Fibrillation |
1.9% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Disseminated Tuberculosis |
1.7% |
| Ill-defined Disorder |
1.7% |
|
| International Normalised Ratio Increased |
9.6% |
| Bradycardia |
8.5% |
| Thrombocytopenia |
8.5% |
| Pneumonia |
7.4% |
| Renal Failure |
7.4% |
| Clostridium Difficile Colitis |
6.4% |
| Urticaria |
6.4% |
| Vomiting |
6.4% |
| Rhabdomyolysis |
5.3% |
| Cytolytic Hepatitis |
4.3% |
| Electrocardiogram Qt Prolonged |
4.3% |
| Drug Exposure During Pregnancy |
3.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.2% |
| Sudden Death |
3.2% |
| Tendon Rupture |
3.2% |
| Vertigo |
3.2% |
| Xerophthalmia |
3.2% |
| Corneal Deposits |
2.1% |
| Diarrhoea |
2.1% |
| Hypersensitivity |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
53.5% |
| Prophylaxis |
4.1% |
| Multiple Myeloma |
3.9% |
| Pain |
3.9% |
| Pneumonia |
3.5% |
| Hiv Infection |
3.3% |
| Non-small Cell Lung Cancer |
3.0% |
| Tuberculosis |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Hypertension |
2.6% |
| Constipation |
2.3% |
| Acute Lymphocytic Leukaemia |
1.9% |
| Acute Myeloid Leukaemia |
1.9% |
| Nausea |
1.8% |
| Asthma |
1.5% |
| Pulmonary Tuberculosis |
1.5% |
| Breast Cancer |
1.4% |
| Infection |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Renal Transplant |
1.4% |
|
| Vomiting |
12.7% |
| Pyrexia |
8.5% |
| Weight Decreased |
7.7% |
| White Blood Cell Count Decreased |
7.0% |
| Renal Failure Acute |
5.6% |
| Sepsis |
5.6% |
| Toxic Epidermal Necrolysis |
5.6% |
| White Blood Cell Count Increased |
5.6% |
| Respiratory Failure |
4.9% |
| Somnolence |
4.9% |
| Urticaria |
4.2% |
| Viral Haemorrhagic Cystitis |
4.2% |
| Thrombocytopenia |
3.5% |
| Hypoxia |
2.8% |
| International Normalised Ratio Increased |
2.8% |
| Prostate Cancer |
2.8% |
| Pulmonary Embolism |
2.8% |
| Rash Vesicular |
2.8% |
| Renal Failure |
2.8% |
| Serotonin Syndrome |
2.8% |
|
| Interacting |
| Pneumonia |
31.1% |
| Breast Cancer Metastatic |
16.4% |
| Pain |
9.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
8.2% |
| Renal Failure Chronic |
8.2% |
| Mitral Valve Replacement |
6.6% |
| Drug Use For Unknown Indication |
4.9% |
| Lung Infection |
4.9% |
| Pyrexia |
3.3% |
| Anticoagulant Therapy |
1.6% |
| Depression |
1.6% |
| Respiratory Tract Infection |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
|
| International Normalised Ratio Increased |
33.3% |
| Pseudomembranous Colitis |
33.3% |
| Drug Interaction |
8.3% |
| Electrocardiogram Qt Prolonged |
8.3% |
| Peritoneal Haemorrhage |
8.3% |
| Urinary Tract Infection |
8.3% |
|
